Torrent Pharmaceuticals Ltd.'s consolidated net profit surged 11% in the fourth quarter of financial year 2025, according to an exchange filing on Tuesday.
The pharma company's bottom line stood at Rs 498 crore during January- March period in comparison to Rs 449 crore in the year-ago period.
Torrent Pharma Q4 Highlights (Consolidated, YoY)
Revenue up 7.8% to Rs 2,959 crore versus Rs 2,745 crore.
Ebitda up 9% to Rs 964 crore versus Rs 883 crore.
Margin expands to 32.6% versus 32.2%.
Net profit up 11% to Rs 498 crore versus Rs 449 crore.
Dividend
The board of Torrent Pharma recommended a final dividend of Rs 6 per share at a face value of Rs 5 each. The record date for the same is set as June 20.
If approved by the shareholders, then the proposed dividend will be paid to the eligible shareholders in August. In the previous quarter, the company dispatched an interim dividend of Rs 26 per share.
In the upcoming annual general meeting, the board of Torrent Pharma will seek approval for raising funds up to Rs 5,000 crore through the issuance of shares, including convertible bonds or debentures, via qualified institutional placement or other modes.
The board will also appoint Aman Mehta, current whole-time director of the company, as the managing director and whole-time key managerial personnel for a period of five years from Aug 1, subject to the approval from the required stakeholders at the AGM.
Shares of Torrent Pharma closed 1.86% lower at Rs 3,241.5 apiece on the NSE ahead of the results, compared to a 0.96% fall in the benchmark Nifty. The stock has risen 20.87% in the last 12 months but fallen 3.53% on a year-to-date basis.
RECOMMENDED FOR YOU
Torrent Expects JB Pharma Deal To Reach Completion Over 15-18 Months
Jul 01, 2025
Torrent Pharma Target Price Hiked By BofA On Likely Margin Synergies After JB Deal
Jul 01, 2025
Torrent Pharma To Acquire Controlling Stake In JB Chemicals From KKR For Rs 25,689 Crore
Jun 30, 2025
Torrent Pharma – JB Chemicals Acquisition: What Should JB Chemicals Shareholders Do?
Jun 30, 2025
POPULAR